Klein Lawrence Otto Insider Trading Activity (ORKA)

Summary

Updated Jul 16, 2026

Klein Lawrence Otto has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $192K.

Profile

Klein Lawrence Otto is identified in SEC filings as the Chief Executive Officer of Oruka Therapeutics, Inc. as of March 17, 2026. The available SEC filing context confirms his current role and affiliation with Oruka Therapeutics but does not disclose additional background details such as education or prior career history. Based on the provided context, there is no indication that he is deceased as of the filing date.

Role	Chief Executive Officer, Director
Notability	25/100

Board memberships

Oruka Therapeutics, Inc.

Awards & honors

CEO of Oruka Therapeutics, Inc. (as of 2026-03-17)

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-15	ORKA	Oruka Therapeutics, Inc.	S — Open-market sale	1.7K	$69.69	$120K
2026-03-17	ORKA	Oruka Therapeutics, Inc.	S — Open-market sale	1.7K	$41.30	$71K
2026-01-23	ORKA	Oruka Therapeutics, Inc.	A — Grant or award	76.7K	$0.00

Frequently Asked Questions

Who is Klein Lawrence Otto?

How many SEC Form 4 filings has Klein Lawrence Otto submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Klein Lawrence Otto been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($192K) across all tracked filings.

Where can I see all of Klein Lawrence Otto's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Klein Lawrence Otto — SEC Form 4 Insider Trading Activity